Apr 12, 2022 Health Canada Has Approved ZEPOSIA® (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis Learn moreEn savoir plus
Feb 4, 2022 Nova Scotia’s IBD Patients Have Been Patient: Now They're Asking The Government To Be Patient, Too Learn moreEn savoir plus
Feb 3, 2022 Takeda Canada Awards $1 Million To Support The Canadian IBD Research Consortium Learn moreEn savoir plus